Evidence map›Paper›PMID 33093565›Full record

ArticleScientific reports2020

Adenosine and ATPγS protect against bacterial pneumonia-induced acute lung injury.

Christine M Gross, Anita Kovacs-Kasa, Mary Louise Meadows, Mary Cherian-Shaw, David J Fulton, Alexander D Verin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Integration of the Microbiome, Metabolome and Transcriptome RevealsAnimals : an open access journal from MDPI · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Anti-Inflammatory Metabolites in the Pathogenesis of Bacterial Infection.Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christine M GrossPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA.ORCID 0000-0002-7453-3235
Anita Kovacs-KasaPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA.
Mary Louise MeadowsPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA.
Mary Cherian-ShawPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA.
David J FultonPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA.
Alexander D VerinPulmonary Division, Vascular Biology Center, Medical College of Georgia, Augusta University, 1459 Laney Walker Blvd, CB 3210-A, Augusta, GA, 30912, USA. averin@augusta.edu.
Augusta University · US

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
American Heart Association-American Stroke Association 18POST33990193NHLBI NIH HHS P01 HL101902NIH HHS P01HL0101902
6 · The paper itself

Abstract

Lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria, disrupts the alveolar-capillary barrier, triggering pulmonary vascular leak thus inducing acute lung injury (ALI). Extracellular purines, adenosine and ATP, protected against ALI induced by purified LPS. In this study, we investigated whether these purines can impact vascular injury in more clinically-relevant E.coli (non-sterile LPS) murine ALI model. Mice were inoculated with live E. coli intratracheally (i.t.) with or without adenosine or a non-hydrolyzable ATP analog, adenosine 5'-(γ-thio)-triphosphate (ATPγS) added intravenously (i.v.). After 24 h of E. coli treatment, we found that injections of either adenosine or ATPγS 15 min prior or adenosine 3 h after E.coli insult significantly attenuated the E.coli-mediated increase in inflammatory responses. Furthermore, adenosine prevented weight loss, tachycardia, and compromised lung function in E. coli-exposed mice. Accordingly, treatment with adenosine or ATPγS increased oxygen saturation and reduced histopathological signs of lung injury in mice exposed to E. coli. Lastly, lung-targeting gene delivery of adenosine or ATPγS downstream effector, myosin phosphatase, significantly attenuated the E. coli-induced compromise of lung function. Collectively, our study has demonstrated that adenosine or ATPγS mitigates E. coli-induced ALI in mice and may be useful as an adjuvant therapy in future pre-clinical studies.

Indexed as

Acute Lung InjuryAdenosineAdenosine TriphosphateAffinity LabelsAnimalsEscherichia coliMaleMiceMice, Inbred C57BLPneumonia, BacterialVasodilator AgentsAdenosineadenosine 5'-O-(3-thiotriphosphate)Adenosine TriphosphateAffinity LabelsVasodilator Agents

Identifiers

PMID33093565
PMCPMC7581771
OpenAlexW3094057888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.